Robson, Mark E. http://orcid.org/0000-0002-3109-1692
Im, Seock-Ah
Senkus, Elzbieta
Xu, Binghe
Domchek, Susan M.
Masuda, Norikazu
Delaloge, Suzette
Tung, Nadine
Armstrong, Anne http://orcid.org/0000-0002-0774-7006
Dymond, Mike http://orcid.org/0000-0001-5981-391X
Fielding, Anitra
Allen, Allison
Conte, Pierfranco http://orcid.org/0000-0002-5210-5344
Funding for this research was provided by:
NCI
AstraZeneca PLC
This article is maintained by: Elsevier
Article Title: OlympiAD extended follow-up for overall survival and safety: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
Journal Title: European Journal of Cancer
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejca.2023.01.031
Content Type: article
Copyright: © 2023 The Authors. Published by Elsevier Ltd.